GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (TSX:RVX) » Definitions » Effect of Exchange Rate Changes

Resverlogix (TSX:RVX) Effect of Exchange Rate Changes : C$0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2005. Start your Free Trial

What is Resverlogix Effect of Exchange Rate Changes?

Resverlogix's Effect of Exchange Rate Changes for the three months ended in Mar. 2025 was C$0.00 Mil.

Resverlogix's Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Mar. 2025 was C$0.00 Mil.


Resverlogix Effect of Exchange Rate Changes Historical Data

The historical data trend for Resverlogix's Effect of Exchange Rate Changes can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resverlogix Effect of Exchange Rate Changes Chart

Resverlogix Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23 Dec24
Effect of Exchange Rate Changes
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 -0.04 -0.02 - -

Resverlogix Quarterly Data
Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Effect of Exchange Rate Changes Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Resverlogix Effect of Exchange Rate Changes Calculation

Effect of Exchange Rate Changes represents the effect of exchange rate changes on cash balances held in foreign currencies.

Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Resverlogix Effect of Exchange Rate Changes Related Terms

Thank you for viewing the detailed overview of Resverlogix's Effect of Exchange Rate Changes provided by GuruFocus.com. Please click on the following links to see related term pages.


Resverlogix Business Description

Industry
Traded in Other Exchanges
Address
4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
Executives
Aaron Bradley Cann Senior Officer
Donald J. Mccaffrey Director, Senior Officer
Kenneth Eugene Lebioda Senior Officer
Dr. Jan Ove Johansson Senior Officer

Resverlogix Headlines

No Headlines